Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $72.7B
1-Year Return 14.89%
This Quarter Return
-11.4%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$54.3B
AUM Growth
-$7.49B
Cap. Flow
-$884M
Cap. Flow %
-1.63%
Top 10 Hldgs %
23.98%
Holding
1,169
New
106
Increased
312
Reduced
371
Closed
129

Sector Composition

1 Technology 17.16%
2 Healthcare 14.07%
3 Financials 12.95%
4 Industrials 11.97%
5 Communication Services 11.59%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
INVA icon
901
Innoviva
INVA
$1.29B
$7K ﹤0.01%
+430
New +$7K
LTC
902
LTC Properties
LTC
$1.69B
$7K ﹤0.01%
+191
New +$7K
SABR icon
903
Sabre
SABR
$675M
$7K ﹤0.01%
+344
New +$7K
SKT icon
904
Tanger
SKT
$3.94B
$7K ﹤0.01%
+358
New +$7K
CLX icon
905
Clorox
CLX
$15.5B
$6K ﹤0.01%
42
-30,265
-100% -$4.32M
DGX icon
906
Quest Diagnostics
DGX
$20.5B
$6K ﹤0.01%
81
-16
-16% -$1.19K
GS icon
907
Goldman Sachs
GS
$223B
$5K ﹤0.01%
31
SCCO icon
908
Southern Copper
SCCO
$83.6B
$5K ﹤0.01%
171
+58
+51% +$1.7K
CSOD
909
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$5K ﹤0.01%
+100
New +$5K
BFS
910
Saul Centers
BFS
$812M
$4K ﹤0.01%
+99
New +$4K
TCOM icon
911
Trip.com Group
TCOM
$47.6B
$4K ﹤0.01%
180
-769,144
-100% -$17.1M
UNIT
912
Uniti Group
UNIT
$1.59B
$4K ﹤0.01%
+273
New +$4K
TWTR
913
DELISTED
Twitter, Inc.
TWTR
$4K ﹤0.01%
154
DVA icon
914
DaVita
DVA
$9.86B
$3K ﹤0.01%
69
EXPE icon
915
Expedia Group
EXPE
$26.6B
$3K ﹤0.01%
31
-2,793
-99% -$270K
QD
916
Qudian
QD
$733M
$3K ﹤0.01%
800
-24,400
-97% -$91.5K
STOR
917
DELISTED
STORE Capital Corporation
STOR
$3K ﹤0.01%
110
CMS icon
918
CMS Energy
CMS
$21.4B
$2K ﹤0.01%
48
COO icon
919
Cooper Companies
COO
$13.5B
$2K ﹤0.01%
44
DOX icon
920
Amdocs
DOX
$9.46B
$2K ﹤0.01%
38
-78,462
-100% -$4.13M
FE icon
921
FirstEnergy
FE
$25.1B
$2K ﹤0.01%
61
GD icon
922
General Dynamics
GD
$86.8B
$2K ﹤0.01%
13
-5,082
-100% -$782K
HRL icon
923
Hormel Foods
HRL
$14.1B
$2K ﹤0.01%
+54
New +$2K
NDAQ icon
924
Nasdaq
NDAQ
$53.6B
$2K ﹤0.01%
102
REGN icon
925
Regeneron Pharmaceuticals
REGN
$60.8B
$2K ﹤0.01%
6